Literature DB >> 13428488

The risk of inducing constitutional reactions in allergic patients.

P P VANARSDEL, W B SHERMAN.   

Abstract

Entities:  

Keywords:  ALLERGY/therapy

Mesh：

Year:  1957        PMID： 13428488     DOI： 10.1016/0021-8707(57)90130-2

Source DB:  PubMed          Journal:  J Allergy        ISSN： 0021-8707


× No keyword cloud information.
  6 in total

Review 1.  Skin tests.

Authors:  B Guerin; R D Watson
Journal:  Clin Rev Allergy       Date:  1988

Review 2.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

Review 3.  Fatalities following allergen immunotherapy.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

4.  Skin testing for allergy in children.

Authors: 
Journal:  Can Med Assoc J       Date:  1983-10-15       Impact factor: 8.262

5.  Dimethpyrindene. Use in high dosage hyposensitization therapy; prevention of constitutional and excessive local reactions.

Authors:  M M HARTMAN
Journal:  Calif Med       Date:  1962-04

Review 6.  Safety considerations in assessing the role of immunotherapy in allergic disorders.

Authors:  J Bousquet; F B Michel
Journal:  Drug Saf       Date:  1994-01       Impact factor: 5.606
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.